Magdalene K. Sgagias

Array ( [id] => 10323617 [patent_doc_number] => 20150208621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-30 [patent_title] => 'Transgenic Animal' [patent_app_type] => utility [patent_app_number] => 14/420638 [patent_app_country] => US [patent_app_date] => 2013-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20157 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14420638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9330151 [patent_doc_number] => 20140056933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'IMMUNOSTIMULATORY NUCLEIC ACID PACKAGED PARTICLES FOR THE TREATMENT OF HYPERSENSITIVITY' [patent_app_type] => utility [patent_app_number] => 13/947577 [patent_app_country] => US [patent_app_date] => 2013-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 54301 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13947577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11389774 [patent_doc_number] => 09551010 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-24 [patent_title] => 'Methods of improving retroviral titer in transfection-based production system using eukaryotic cells' [patent_app_type] => utility [patent_app_number] => 13/946746 [patent_app_country] => US [patent_app_date] => 2013-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 9 [patent_no_of_words] => 4742 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13946746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10281960 [patent_doc_number] => 20150166958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'BROWN FAT CELLS AND METHOD FOR PREPARING SAME' [patent_app_type] => utility [patent_app_number] => 14/413987 [patent_app_country] => US [patent_app_date] => 2013-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 12361 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14413987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12449265 [patent_doc_number] => 09982275 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-29 [patent_title] => Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases [patent_app_type] => utility [patent_app_number] => 13/936728 [patent_app_country] => US [patent_app_date] => 2013-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 6 [patent_no_of_words] => 12050 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13936728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9211610 [patent_doc_number] => 20140010787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'ONCOLYTIC RHABDOVIRUS' [patent_app_type] => utility [patent_app_number] => 13/937043 [patent_app_country] => US [patent_app_date] => 2013-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 33963 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13937043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11250374 [patent_doc_number] => 09475865 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-25 [patent_title] => 'Direct administration of REIC/Dkk-3 to mesothelioma' [patent_app_type] => utility [patent_app_number] => 13/925041 [patent_app_country] => US [patent_app_date] => 2013-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6933 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13925041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10282023 [patent_doc_number] => 20150167020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'SITE-SPECIFIC INTEGRATION' [patent_app_type] => utility [patent_app_number] => 14/409283 [patent_app_country] => US [patent_app_date] => 2013-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14900 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14409283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10226304 [patent_doc_number] => 20150111296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-23 [patent_title] => 'Transcription Factor Mediated Programming Towards Megakaryocytes' [patent_app_type] => utility [patent_app_number] => 14/407044 [patent_app_country] => US [patent_app_date] => 2013-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13762 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14407044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9293950 [patent_doc_number] => 20140037584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'ONCOLYTIC RHABDOVIRUS' [patent_app_type] => utility [patent_app_number] => 13/919787 [patent_app_country] => US [patent_app_date] => 2013-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 33957 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13919787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10960863 [patent_doc_number] => 20140363892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'REGULATORY ELEMENTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/915522 [patent_app_country] => US [patent_app_date] => 2013-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25999 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13915522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10265966 [patent_doc_number] => 20150150963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-04 [patent_title] => 'VACCINATION WITH INTERLEUKIN-4 ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 14/405704 [patent_app_country] => US [patent_app_date] => 2013-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 20522 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14405704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9537711 [patent_doc_number] => 20140162359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'Differentiation of Human Embryonic Stem Cells into Pancreatic Endoderm' [patent_app_type] => utility [patent_app_number] => 13/888968 [patent_app_country] => US [patent_app_date] => 2013-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8955 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13888968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9004541 [patent_doc_number] => 20130225666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'DELIVERY OF POLYNUCLEOTIDES USING RECOMBINANT AAV9' [patent_app_type] => utility [patent_app_number] => 13/830515 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 18028 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13830515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9149071 [patent_doc_number] => 20130303595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'Compositions and Methods for Treating Glioblastoma GBM' [patent_app_type] => utility [patent_app_number] => 13/826303 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23624 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13826303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9410533 [patent_doc_number] => 20140101785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-10 [patent_title] => 'GENETICALLY ENCODED CALCIUM INDICATORS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/801120 [patent_app_country] => US [patent_app_date] => 2013-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16840 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13801120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10202606 [patent_doc_number] => 20150087594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'INDUCED NEURAL STEM CELLS' [patent_app_type] => utility [patent_app_number] => 14/387126 [patent_app_country] => US [patent_app_date] => 2013-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10280 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14387126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9083515 [patent_doc_number] => 20130269045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-10 [patent_title] => 'HB-EGF DEFICIENT TRANSGENIC ANIMAL AND PRODUCTION METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 13/756247 [patent_app_country] => US [patent_app_date] => 2013-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11665 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13756247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8829330 [patent_doc_number] => 20130130375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'USE OF FIBROBLAST GROWTH FACTOR FOR LINEAGE PRIMING AND DIFFERENTIATION OF PLURIPOTENT STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/745562 [patent_app_country] => US [patent_app_date] => 2013-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3817 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13745562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8829343 [patent_doc_number] => 20130130388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'Methods of Modifying Eurakyotic Cells' [patent_app_type] => utility [patent_app_number] => 13/719842 [patent_app_country] => US [patent_app_date] => 2012-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13302 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13719842 [rel_patent_id] =>[rel_patent_doc_number] =>)